Sponsor content
30 result(s) found, displaying 11 to 20
-
Australian public assessment report (AusPar)New AusPAR for VUMERITY (diroximel fumarate) to reduce relapses and delay progression of disability in multiple sclerosis patients.
-
Cancellation by sponsorRequested by Biogen Australia Pty Ltd
-
Cancellation by sponsorRequested by Biogen Australia Pty Ltd
-
Prescription medicine decision summaryTGA Decision: Vumerity (diroximel fumarate) is approved to treat relapsing multiple sclerosis.
-
Prescription medicine registrationActive ingredients: diroximel fumarate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SPINRAZA nusinersen (as heptadecasodium) 12 mg/ 5 mL solution for injection vial.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Nusinersen (as heptadecasodium)
-
Cancellation by sponsorRequested by Biogen Australia Pty Ltd
-
Cancellation by sponsorRequested by Biogen Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PLEGRIDY peginterferon beta-1a (rch) 125 microgram/0.5 mL solution for injection pre-filled syringe.